Target Name: WBP1
NCBI ID: G23559
Other Name(s): WBP-1 | WBP1_HUMAN | WW domain-binding protein 1 | WW domain binding protein 1 | epididymis secretory sperm binding protein

WBP1: A Potential Drug Target and Biomarker

WBP-1 (Western blot-1) is a protein that is expressed in various tissues and cell types in the human body. It is a member of the TATA-protein family, which is known for its role in regulating gene expression and cell signaling. WBP-1 has been shown to play a role in the regulation of cell proliferation, differentiation, and survival.

One of the key functions of WBP-1 is its ability to interact with and regulate the activity of the transcription factor, p53. p53 is a well-known protein that plays a critical role in the regulation of cell growth and division, and is often involved in the development and progression of cancer.

WBP-1 has been shown to work in concert with p53 to regulate the activity of target genes that are involved in cell growth, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels). These interactions between WBP-1 and p53 have important implications for the regulation of cellular processes that are critical for normal development, growth, and function.

In addition to its role in regulating p53 activity, WBP-1 has also been shown to interact with and influence the activity of several other transcription factors, including NF-kappa-B (nuclear factor kappa B), AP-1, and STAT3. These interactions between WBP-1 and these other transcription factors have important implications for the regulation of a wide range of cellular processes, including cell signaling, inflammation, and stress response.

The potential implications of WBP-1 as a drug target are significant. If an inhibitor of WBP-1 can be developed, it could potentially be used to treat a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because WBP-1 is involved in the regulation of many important cellular processes that are involved in the development and progression of these diseases.

In addition to its potential as a drug target, WBP-1 has also been shown to be a potential biomarker for a variety of diseases. For example, high levels of WBP-1 have been shown to be associated with the development of certain types of cancer, and inhibition of WBP-1 has been shown to be effective in treating these cancers. In addition, WBP-1 has also been shown to be involved in the regulation of cellular stress response, and may be an useful biomarker for Assessing the efficacy of stress-reducing treatments.

The identification and characterization of WBP-1 as a potential drug target and biomarker is an important step in the development of new treatments for a wide range of diseases. Further research is needed to fully understand the role of WBP-1 in cellular processes and its potential as a drug and biomarker.

Protein Name: WW Domain Binding Protein 1

More Common Targets

WBP11 | WBP11P1 | WBP1L | WBP2 | WBP2NL | WBP4 | WDCP | WDFY1 | WDFY2 | WDFY3 | WDFY3-AS2 | WDFY4 | WDHD1 | WDPCP | WDR1 | WDR11 | WDR11-DT | WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88 | WDR89 | WDR90 | WDR91 | WDR93 | WDR97 | WDSUB1 | WDTC1 | WEE1 | WEE2 | WEE2-AS1 | WFDC1 | WFDC10A | WFDC10B | WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2